ReviewDrugs2025

Tafolecimab, a Third Monoclonal Antibody for PCSK9 as the Novel Lipid-Lowering Drug Around the World: A Narrative Review.

Hui-Hui Liu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.